| Dr Jolene L Chan, PHARMD | |
|
867 Island Dr, Alameda, CA 94502-6751 | |
| (510) 521-4833 | |
| Not Available |
| Full Name | Dr Jolene L Chan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 867 Island Dr, Alameda, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972804953 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 48810 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jolene L Chan, PHARMD 867 Island Dr, Alameda, CA 94502-6751 Ph: (510) 710-8300 | Dr Jolene L Chan, PHARMD 867 Island Dr, Alameda, CA 94502-6751 Ph: (510) 521-4833 |
News Archive
Scientists at the Morgridge Institute for Research have discovered a promising new target to fight a class of viruses responsible for health threats such as Zika, polio, dengue, SARS and hepatitis C.
Inimex Pharmaceuticals and SARomics Biostructures announce that they have achieved a scientific milestone in their collaboration to solve the structure of Inimex's Innate Defense Regulator (IDR) IMX942 in complex with its target, the ZZ domain of human p62 (sequestosome-1). No structures were previously available for this challenging protein domain. The crystal structure determined by SARomics Biostructures provides invaluable information that will assist the functional understanding of IMX942 and the development of the new generation of IDRs.
The University of Chicago Medicine's Center for Interdisciplinary Inquiry and Innovation in Sexual and Reproductive Health has launched a research initiative aimed at reducing HIV infection and transmission among vulnerable youth of color, including young men who have sex with men and young transgender women.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
Immunetics, Inc. today announced it has been awarded a $2.4 million, 3-year Phase II SBIR grant by the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to support clinical trials of the company's new confirmatory test for Chagas' disease, a serious and potentially fatal parasitic infection.
› Verified 2 days ago
Michael Leong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2314 Santa Clara Ave, Alameda, CA 94501 Phone: 510-523-4929 Fax: 510-523-3430 | |
Sayed Wahidudeen Hashemi, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1160 Broadway Apt A, Alameda, CA 94501 Phone: 510-523-4612 | |
Mrs. Virgette Wong Dumaguin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1916 Webster St, Alameda, CA 94501 Phone: 510-864-2800 Fax: 510-864-2869 | |
Elliott Gorelick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3235 Sterling Ave, Alameda, CA 94501 Phone: 510-427-9299 | |
Dr. Peter Kim, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1916 Webster St, Alameda, CA 94501 Phone: 510-864-2800 Fax: 510-864-2869 | |
Ramon Tran Tang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1240 S Loop Rd, Alameda, CA 94502 Phone: 510-747-4500 | |
Mr. Bryant Waishing Lee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 319 Hollister Ave, Alameda, CA 94501 Phone: 510-529-8545 |